UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells

Arthritis & rheumatology (Hoboken, N.J.), 2016-05, Vol.68 (5), p.1210-1221

2016

Volltextzugriff (PDF)

Increased Frequency of a Unique Spleen Tyrosine Kinase Bright Memory B Cell Population in Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2014-12, Vol.66 (12), p.3424-3435

2014

Volltextzugriff (PDF)

TLR2 Is One of the Endothelial Receptors for β2-Glycoprotein I

The Journal of immunology (1950), 2010-08, Vol.185 (3), p.1550-1557

2010

Volltextzugriff (PDF)

Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis

Journal of rheumatology, 2008-07, Vol.35 (7), p.1256

2008

Volltextzugriff (PDF)

Secondary immunization generates clonally related antigen-specific plasma cells and memory B cells

The Journal of immunology (1950), 2010-09, Vol.185 (5), p.3103-3110

2010

Volltextzugriff (PDF)

Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus

Arthritis research & therapy, 2010-01, Vol.12 (6), p.R204-R204, Article R204

2010

Volltextzugriff (PDF)

Splenic proliferative lymphoid nodules distinct from germinal centers are sites of autoantigen stimulation in immune thrombocytopenia

Blood, 2012-12, Vol.120 (25), p.5021-5031

2012

Volltextzugriff (PDF)

BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer

Journal of Clinical Immunology, 2007-05, Vol.27 (3), p.257-265

2007

Volltextzugriff (PDF)

TLR2 is one of the endothelial receptors for beta 2-glycoprotein I

The Journal of immunology (1950), 2010-08, Vol.185 (3), p.1550-1557

2010

Volltextzugriff (PDF)

Ectopic Germinal Centers Are Rare in Sjogren's Syndrome Salivary Glands and Do Not Exclude Autoreactive B Cells

The Journal of immunology (1950), 2009-03, Vol.182 (6), p.3540-3547

2009

Volltextzugriff (PDF)

Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients

Arthritis research & therapy, 2015-07, Vol.17 (1), p.185-185, Article 185

2015

Volltextzugriff (PDF)

BAFF Overexpression Is Associated with Autoantibody Production in Autoimmune Diseases

Annals of the New York Academy of Sciences, 2005-06, Vol.1050 (1), p.34-39

2005

Volltextzugriff (PDF)

Diminished B cell response and peripheral B cell abnormalities in patients with SLE are linked to disturbances of the spleen tyrosine kinase (P4056)

The Journal of immunology (1950), 2013-05, Vol.190 (1_Supplement), p.44-44.13

2013

Volltextzugriff (PDF)

Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximab

Blood, 2010-12, Vol.116 (24), p.5181-5190

2010

Volltextzugriff (PDF)

Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation

Arthritis research & therapy, 2014-11, Vol.16 (6), p.477-477, Article 477

2014

Volltextzugriff (PDF)

What do we know about memory B cells in primary Sjögren's syndrome?

Autoimmunity reviews, 2010-07, Vol.9 (9), p.600-603

2010

Volltextzugriff (PDF)

Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-[alpha], but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients

Arthritis research & therapy, 2015-07, Vol.17

2015

Volltextzugriff (PDF)

BAFF, APRIL, TWE-PRIL: Who's who?

Autoimmunity reviews, 2008-02, Vol.7 (4), p.267-271

2008

Volltextzugriff (PDF)

Engagement of CD22 on B cells with the monoclonal antibody epratuzumab stimulates the phosphorylation of upstream inhibitory signals of the B cell receptor

Journal of cell communication and signaling, 2016-06, Vol.10 (2), p.143-151

2016

Volltextzugriff (PDF)

New ELISA for B Cell-Activating Factor

Clinical biochemistry, 2009-10, Vol.55 (10), p.1843-1851

2009

Volltextzugriff (PDF)

What do we know about memory B cells in primary Sjoegren's syndrome?

Autoimmunity reviews, 2010-07, Vol.9 (9), p.600-603

2010

Volltextzugriff (PDF)

Anticytokine therapy impacting on B cells in autoimmune diseases

Current opinion in rheumatology, 2009-05, Vol.21 (3), p.205-210

2009

Volltextzugriff (PDF)

The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expression

Arthritis research & therapy, 2012-03, Vol.14 (2), p.R54-R54, Article R54

2012

Volltextzugriff (PDF)

Correction: Secondary Immunization Generates Clonally Related Antigen-Specific Plasma Cells and Memory B Cells

The Journal of immunology (1950), 2014-01, Vol.192 (1), p.535-535

2014

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Humans
(28)
Life Sciences & Biomedicine
(28)
Adult
(13)
B-Lymphocytes - Immunology
(13)
Female
(13)
Rheumatology
(13)
Immunology
(12)
Male
(12)
Middle Aged
(11)
Aged
(9)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
B-Lymphocytes - Metabolism
(8)
B-Lymphocytes - Pathology
(7)
Life Sciences
(7)
Sjogren's Syndrome - Immunology
(7)
B Cells
(6)
B-Lymphocyte Subsets - Immunology
(6)
Lupus Erythematosus, Systemic - Immunology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells

Increased Frequency of a Unique Spleen Tyrosine Kinase Bright Memory B Cell Population in Systemic Lupus Erythematosus

TLR2 Is One of the Endothelial Receptors for β2-Glycoprotein I

Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis

Secondary immunization generates clonally related antigen-specific plasma cells and memory B cells

Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus

Splenic proliferative lymphoid nodules distinct from germinal centers are sites of autoantigen stimulation in immune thrombocytopenia

BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer

IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases

TLR2 is one of the endothelial receptors for beta 2-glycoprotein I

Ectopic Germinal Centers Are Rare in Sjogren's Syndrome Salivary Glands and Do Not Exclude Autoreactive B Cells

Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients

BAFF Overexpression Is Associated with Autoantibody Production in Autoimmune Diseases

Diminished B cell response and peripheral B cell abnormalities in patients with SLE are linked to disturbances of the spleen tyrosine kinase (P4056)

Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximab

Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation

What do we know about memory B cells in primary Sjögren's syndrome?

Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-[alpha], but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients

BAFF, APRIL, TWE-PRIL: Who's who?

Engagement of CD22 on B cells with the monoclonal antibody epratuzumab stimulates the phosphorylation of upstream inhibitory signals of the B cell receptor

New ELISA for B Cell-Activating Factor

What do we know about memory B cells in primary Sjoegren's syndrome?

Anticytokine therapy impacting on B cells in autoimmune diseases

The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expression

Correction: Secondary Immunization Generates Clonally Related Antigen-Specific Plasma Cells and Memory B Cells

Suchergebnisse filtern